Colony Family Offices’s Johnson & Johnson JNJ Stock Holding History

Colony Family Offices’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-4,595	Closed	-$712K	–	72
2023 Q1	$712K	Hold	4,595	–	–	0.27%	43
2022 Q4	$812K	Sell	4,595 -20	-0.4%	-$3.45K	0.34%	34
2022 Q3	$754K	Sell	4,615 -154	-3%	-$26.1K	0.33%	36
2022 Q2	$847K	Buy	+4,769	New	+$850K	0.38%	31
2021 Q2	–	Sell	-5,234	Closed	-$860K	–	38
2021 Q1	$860K	Buy	+5,234	New	+$847K	0.68%	17

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Colony Family Offices's JNJ Position: Q2 2023 in Review

Colony Family Offices sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 4,595 shares — an estimated $712K sold.

Colony Family Offices first reported a position in JNJ in Q1 2021 and held it in 5 quarters. The position peaked at $860K in Q1 2021. 3,752 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

Colony Family Offices reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
Colony Family Offices sold 4,595 Johnson & Johnson shares in Q2 2023, an estimated $712K.
Colony Family Offices first reported a position in Johnson & Johnson in Q1 2021 and held it in 5 quarters.
Colony Family Offices's Johnson & Johnson position peaked at $860K in Q1 2021.
3,752 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Colony Family Offices's 13F filing for Q2 2023, filed 27 Jul 2023.